Logo image of SSTI

SOUNDTHINKING INC (SSTI) Stock Fundamental Analysis

USA - NASDAQ:SSTI - US82536T1079 - Common Stock

11.6 USD
-0.68 (-5.54%)
Last: 9/25/2025, 2:45:06 PM
Fundamental Rating

3

Taking everything into account, SSTI scores 3 out of 10 in our fundamental rating. SSTI was compared to 279 industry peers in the Software industry. Both the profitability and financial health of SSTI have multiple concerns. SSTI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

SSTI had negative earnings in the past year.
SSTI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SSTI reported negative net income in multiple years.
Each year in the past 5 years SSTI had a positive operating cash flow.
SSTI Yearly Net Income VS EBIT VS OCF VS FCFSSTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

SSTI's Return On Assets of -7.51% is on the low side compared to the rest of the industry. SSTI is outperformed by 60.57% of its industry peers.
SSTI has a Return On Equity (-13.58%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -7.51%
ROE -13.58%
ROIC N/A
ROA(3y)-1.15%
ROA(5y)-1.55%
ROE(3y)-1.94%
ROE(5y)-3.07%
ROIC(3y)N/A
ROIC(5y)N/A
SSTI Yearly ROA, ROE, ROICSSTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

The Gross Margin of SSTI (55.47%) is worse than 66.31% of its industry peers.
In the last couple of years the Gross Margin of SSTI has remained more or less at the same level.
SSTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.81%
GM growth 5Y-0.82%
SSTI Yearly Profit, Operating, Gross MarginsSSTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

3

2. Health

2.1 Basic Checks

SSTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SSTI has been reduced compared to 1 year ago.
The number of shares outstanding for SSTI has been increased compared to 5 years ago.
SSTI has a better debt/assets ratio than last year.
SSTI Yearly Shares OutstandingSSTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SSTI Yearly Total Debt VS Total AssetsSSTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

SSTI has an Altman-Z score of 0.92. This is a bad value and indicates that SSTI is not financially healthy and even has some risk of bankruptcy.
SSTI has a Altman-Z score of 0.92. This is in the lower half of the industry: SSTI underperforms 65.59% of its industry peers.
The Debt to FCF ratio of SSTI is 0.62, which is an excellent value as it means it would take SSTI, only 0.62 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.62, SSTI is in the better half of the industry, outperforming 78.49% of the companies in the same industry.
SSTI has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.05, SSTI perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.62
Altman-Z 0.92
ROIC/WACCN/A
WACC11.34%
SSTI Yearly LT Debt VS Equity VS FCFSSTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

SSTI has a Current Ratio of 0.84. This is a bad value and indicates that SSTI is not financially healthy enough and could expect problems in meeting its short term obligations.
SSTI has a worse Current ratio (0.84) than 79.21% of its industry peers.
A Quick Ratio of 0.84 indicates that SSTI may have some problems paying its short term obligations.
With a Quick ratio value of 0.84, SSTI is not doing good in the industry: 78.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
SSTI Yearly Current Assets VS Current LiabilitesSSTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

5

3. Growth

3.1 Past

The earnings per share for SSTI have decreased strongly by -393.75% in the last year.
The Revenue has been growing slightly by 1.47% in the past year.
The Revenue has been growing by 20.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-393.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)1.47%
Revenue growth 3Y20.61%
Revenue growth 5Y20.15%
Sales Q2Q%-3.97%

3.2 Future

Based on estimates for the next years, SSTI will show a very strong growth in Earnings Per Share. The EPS will grow by 32.58% on average per year.
The Revenue is expected to grow by 11.96% on average over the next years. This is quite good.
EPS Next Y52.52%
EPS Next 2Y32.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.58%
Revenue Next 2Y7.47%
Revenue Next 3Y5.11%
Revenue Next 5Y11.96%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SSTI Yearly Revenue VS EstimatesSSTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
SSTI Yearly EPS VS EstimatesSSTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SSTI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SSTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SSTI Price Earnings VS Forward Price EarningsSSTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SSTI.
Based on the Price/Free Cash Flow ratio, SSTI is valued a bit cheaper than 76.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.07
EV/EBITDA 113.95
SSTI Per share dataSSTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as SSTI's earnings are expected to grow with 32.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.58%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SSTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SOUNDTHINKING INC

NASDAQ:SSTI (9/25/2025, 2:45:06 PM)

11.6

-0.68 (-5.54%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners58.02%
Inst Owner Change3.99%
Ins Owners25.02%
Ins Owner Change-1.68%
Market Cap148.36M
Analysts80
Price Target21.93 (89.05%)
Short Float %1.35%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-45.1%
Min EPS beat(2)-80.4%
Max EPS beat(2)-9.81%
EPS beat(4)0
Avg EPS beat(4)-2021.69%
Min EPS beat(4)-7943.14%
Max EPS beat(4)-9.81%
EPS beat(8)2
Avg EPS beat(8)-995.52%
EPS beat(12)3
Avg EPS beat(12)-897.86%
EPS beat(16)3
Avg EPS beat(16)-1165.14%
Revenue beat(2)1
Avg Revenue beat(2)-0.18%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)3.27%
Revenue beat(4)1
Avg Revenue beat(4)-3.8%
Min Revenue beat(4)-13.87%
Max Revenue beat(4)3.27%
Revenue beat(8)2
Avg Revenue beat(8)-1.85%
Revenue beat(12)2
Avg Revenue beat(12)-2.91%
Revenue beat(16)3
Avg Revenue beat(16)-3.33%
PT rev (1m)-4.87%
PT rev (3m)-4.87%
EPS NQ rev (1m)-73.75%
EPS NQ rev (3m)-286.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-46.08%
Revenue NQ rev (1m)0.39%
Revenue NQ rev (3m)-0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.43
P/FCF 23.07
P/OCF 13.01
P/B 1.99
P/tB 16.41
EV/EBITDA 113.95
EPS(TTM)-0.79
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)0.5
FCFY4.33%
OCF(TTM)0.89
OCFY7.69%
SpS8.12
BVpS5.83
TBVpS0.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.51%
ROE -13.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.47%
FCFM 6.19%
ROA(3y)-1.15%
ROA(5y)-1.55%
ROE(3y)-1.94%
ROE(5y)-3.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.81%
GM growth 5Y-0.82%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.62
Debt/EBITDA 3.09
Cap/Depr 49.83%
Cap/Sales 4.79%
Interest Coverage N/A
Cash Conversion 882.06%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 0.92
F-Score6
WACC11.34%
ROIC/WACCN/A
Cap/Depr(3y)78.06%
Cap/Depr(5y)84.75%
Cap/Sales(3y)8.57%
Cap/Sales(5y)9.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-393.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y52.52%
EPS Next 2Y32.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.47%
Revenue growth 3Y20.61%
Revenue growth 5Y20.15%
Sales Q2Q%-3.97%
Revenue Next Year5.58%
Revenue Next 2Y7.47%
Revenue Next 3Y5.11%
Revenue Next 5Y11.96%
EBIT growth 1Y-130.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year729.43%
EBIT Next 3Y144.94%
EBIT Next 5Y99.94%
FCF growth 1Y49.91%
FCF growth 3Y101.84%
FCF growth 5Y12.45%
OCF growth 1Y-16.81%
OCF growth 3Y31.28%
OCF growth 5Y10.17%